Izaflortaucipir (18F)

6 trials 5 recruiting Orphan designation

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

5 Recruiting

1 Completed trials

4 Sponsors

1 Countries

Phase II

Phase I/II

Phase II: 5 Phase I/II: 1

Indications tested

Progressive supranuclear palsy 2

Sponsors using this IMP

Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau 3 AC Immune S.A. 1 Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer 1 University Clinic Of Navarra 1

All trials

6 total

Quantification tools for a novel tau PET marker in a rare neurological disease: 18F-PI-2620 in progressive supranuclear palsy Recruiting

2023-508718-40-00 Phase II 1 country Fundacio De Recerca Clinic Barcelona-Institut D’investigacions Biomediques Augus…
LONGITUDINAL STUDY OF THE POSITRON EMISSION TOMOGRAPHY (PET) TRACER FOR TAU 18F-PI-2620 IN INDIVIDUALS WITH DOWN SYNDROME Recruiting

2024-515574-27-00 Phase II 1 country Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Longitudinal multicenter head-to-head harmonization of tau PET tracers (HEAD Study) Recruiting

2023-510508-31-01 Phase II 1 country Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
Sleep and body temperature as markers of progression of Alzheimer's disease in Down syndrome. Recruiting

2023-506609-21-00 Phase II 1 country Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
A phase 1b/2, multicenter, adaptive, double-blind, randomized, placebo-controlled study to assess the safety, tolerability, immunogenicity, … Recruiting

2022-500069-29-00 Phase I/II 1 country AC Immune S.A.
ASSESSMENT OF THE BRAIN DEPOSIT OF TAU 4R DETECTED BY BRAIN PET WITH 18F-PI2620 IN PROGRESSIVE SUPRANUCLEAR PALSY COMPARED TO CONTROLS WITHO… Ended

2023-503538-37-00 Phase II 1 country University Clinic Of Navarra

Showing 1–6 of 6 trials

← All drugs A–Z